Vitamin D in children with cystic fibrosis
- Lookup NU author(s)
- Dr Malcolm Brodlie
- Dr David Spencer
|
|
|
|
| Author(s) | | Brodlie M, Orchard WA, Reeks GA, Pattman S, McCabe H, O'Brien CJ, Thomas MF, Spencer DA |
| Publication type | | Article |
| Journal | | Archives of Disease in Childhood |
| Year | | 2012 |
| Volume | | 97 |
| Issue | | 11 |
| Pages | | 982-984 |
| ISSN (print) | | 0003-9888 |
| ISSN (electronic) | | 1468-2044 |
|
|
|
| Full text for this publication is not currently held within this repository. Alternative links are provided below where available. |
|
|
|
|
| Purpose The Cystic Fibrosis Trust in 2007 published a recommended target of 75-150 nmol/L for 25-hydroxyvitamin D (25-OHD). In 2008 we found that only 10% of pancreatic insufficient (PI) children met this target. An increase in supplementation was implemented and a repeat audit performed in 2010.Methods PI children ≥1 year under sole-care in our regional centre were included. Vitamin D3 supplementation increased by >450% to either 3800 IU/day liquid or 800 IU daily plus 20,000 IU weekly tablets. In 2010 pancreatic sufficient (PS) children were also audited separately.Results The median 25-OHD level increased from 51.5 nmol/L in 2008 (n=78, 10% >75 nmol/L) to 72 nmol/L in 2010 (n=72, 51% >75 nmol/L), p<0.0001. In PS children (n=15 in 2010) 87% had 25-OHD levels <75 nmol/L.Conclusions A substantial increase in supplementation led to a significant increase in 25-OHD levels but around half still failed to reach the recommended target. |
|
|
|
| Publisher | | BMJ Group |
| URL | | http://dx.doi.org/10.1136/archdischild-2011-301398 |
| DOI | | 10.1136/archdischild-2011-301398 |
|
|
Actions | |   |
